🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10259+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10259 recruiting trials

Phase 3RecruitingNCT07139873

A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

👨‍⚕️ Study Director, Dizal (Jiangsu) Pharmaceutical Co., Ltd.📍 2 sites📅 Started Sep 2025View details ↗
Enrolling by InvitationNCT06841341

Electrophysiology and Ultrasound of Respiratory Muscles and Respective Nerves to Predict Respiratory Insufficiency in ALS

🏥 Jagiellonian University📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07102901

Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

🏥 Jiangsu HengRui Medicine Co., Ltd.📍 2 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07148791

Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

👨‍⚕️ JIAN ZHU, M.D./Ph.D., Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07029594

Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia

👨‍⚕️ Colin DEBAIGT📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06414590

Neoadjuvant Tebentafusp for Uveal Melanoma

🏥 Thomas Jefferson University📍 2 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07029737

A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain

🏥 AstraZeneca📍 22 sites📅 Started Sep 2025View details ↗
Enrolling by InvitationNCT07081841

AB-1005 Long-Term Follow-up Study

🏥 AskBio Inc📍 2 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07151690

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07207577

Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD

👨‍⚕️ Laurent MESSONNIER, Université Savoie Mont Blanc📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06784726

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

👨‍⚕️ Mengyang Di, MD, PhD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT07106827

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

🏥 West China Hospital📍 1 site📅 Started Sep 2025View details ↗
NAEnrolling by InvitationNCT07235345

To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation

🏥 Xu Falin📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07001059

oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound

👨‍⚕️ Omar AL TABAA, Dr, Hôpital NOVO📍 9 sites📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT07163403

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

🏥 Fundacion Clinic per a la Recerca Biomédica📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07075471

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

👨‍⚕️ Clinical Team, Deciphera Pharmaceuticals, LLC📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT06915454

High-Resolution PET-CT Imaging for Surgical Margin Visualization

👨‍⚕️ Michael Topf, MD, Vanderbilt University/Ingram Cancer Center📍 1 site📅 Started Sep 2025View details ↗
Phase 4RecruitingNCT07135427

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

🏥 University of Alabama at Birmingham📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07163780

The Effect of the HEP Approach in Infants With Down Syndrome

👨‍⚕️ Aymen Balıkcı, Dr. Physiotherapist📍 1 site📅 Started Sep 2025View details ↗
Phase 1, PHASE2RecruitingNCT07093814

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

👨‍⚕️ Chengcheng Guo, Sun Yat-Sen University Cancer Center📍 11 sites📅 Started Sep 2025View details ↗
← PreviousPage 68 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →